Fact · Dictation software
$100million US dollars
Tandem Health announced on 14 September 2026 that it raised $100 million, led by the Scaleup Europe Fund managed by EQT.
Quote found word for word on the live source, last checked October 19, 2026
In the source's own words
“Tandem Health raises $100M led by the Scaleup Europe Fund managed by EQT to bring European healthcare into the AI era”
Tandem Health news list: fundraising announcements, Tandem Health, 2026, Fundraising item dated 14 Sept 2026 in the news list.
Open the original- What it measures
- Tandem sells an AI medical assistant and ambient scribe to clinics and hospitals in Europe. The headline gives the amount and the lead investor.
- What it does not show
- Headline only: the announcement body was not readable, so the valuation and the other investors are not in this fact. The company's list does not call the round a Series B.
In the data
A row of Voice AI Funding: Speech and Dictation Startup Rounds, as Tandem Health, 2026 $100M round: 100 million US dollars.
- Company
- Tandem Health
- Deal
- Growth or unlabeled round
- What the company makes
- Medical scribe or dictation
- Led by or buyer
- Scaleup Europe Fund managed by EQT
- Announced
- 2026-09-14
- Year
- 2026
- Note
- Amount as Tandem's own headline states it, in dollars
Source
Used to calculate
- In the funding rounds and acquisitions in speech recognition and dictation dataset, the 7 published figures for “Medical scribe or dictation” have a median of 50 million US dollars, ranging from 4.2 to 19,700.
- The funding rounds and acquisitions in speech recognition and dictation dataset holds 50 data points, each a published figure traced to its source.
- The funding rounds and acquisitions in speech recognition and dictation dataset draws on 46 distinct sources.